Deep Brain Stimulation Systems Market: Detailed Market Share and Growth Analysis, Competitive Insights, and Trends in Neurological Treatments

The new report published by The Business Research Company, titled " Deep Brain Stimulation Systems Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.28 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13834&type=smp

Rising Prevalence Of Neurological Disorders Ignites Growth In The Deep Brain Stimulation Systems Market
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body's autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson's Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based federal agency, up to 5.8 million Americans suffered from Alzheimer's disease in 2020, and this population is expected to almost triple to 14 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.

Launch Of World's Smallest Rechargeable Deep Brain Stimulation Device With Remote Programming
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician's office.

The deep brain stimulation systems market covered in this report is segmented -

1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13834&type=discount

Major companies operating in the deep brain stimulation systems market report are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation

Contents of the report:
1. Executive Summary
2. Deep Brain Stimulation Systems Market Report Structure
3. Deep Brain Stimulation Systems Market Trends And Strategies
4. Deep Brain Stimulation Systems Market - Macro Economic Scenario
5. Deep Brain Stimulation Systems Market Size And Growth
…..
27. Deep Brain Stimulation Systems Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.